Insights

Gathering insights about Attralus …

Similar companies to Attralus

Attralus Tech Stack

Attralus uses 8 technology products and services including WordPress, CookieYes, MySQL, and more. Explore Attralus 's tech stack below.

WordPress
Content Management System
CookieYes
Cookie Compliance
MySQL
Database
Google Font API
Font Scripts
jQuery
Javascript Libraries
HTTP/3
Miscellaneous
Open Graph
Miscellaneous
OpenResty
Web Servers

Media & News

Attralus, Inc. received financing of $56M in financing on Feb 6th '24.
Attralus closes $56 million financing.
Feb 05, 2024 | www.uaehealthnews.com
Attralus, Inc. hired James Testa as Vice President of Finance on Feb 10th '22.
Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced the appointment of James Testa as Vice President of Finance.
Feb 10, 2022 | www.globenewswire.com
Attralus, Inc. launched preclinical data for AT-03 on Dec 13th '21.
Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced encouraging new preclinical data for AT-03, the company’s first-in-class pan-amyloid removal (PAR) therapeutic being developed for the treatment of systemic amyloidosis.
Dec 13, 2021 | www.biospace.com
Attralus, Inc. received financing of $116M in Series B on Sep 8th '21.
Attralus has raised $116 million to support the clinical development of AT-01, its diagnostic imaging agent for systemic amyloidosis, a group of rare conditions that includes familial amyloid polyneuropathy (FAP).
Sep 26, 2021 | fapnewstoday.com
Attralus, Inc. hired Alexander Denner as Board of Directors on Sep 8th '21.
Today, Attralus also announced that Alexander Denner, Ph.D. has joined the company’s Board of Directors.
Sep 08, 2021 | www.globenewswire.com
Attralus, Inc. hired Jake Bauer as independent director on Jul 28th '21.
Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that Jake Bauer joined the company’s Board of Directors as an independent director.
Jul 28, 2021 | finance.yahoo.com
Attralus, Inc. is developing pan-amyloid removal treatments for systemic amyloidosis.
Attralus is working on pan-amyloid removal treatments for systemic amyloidosis.
May 11, 2021 | www.fiercebiotech.com

Attralus 's Email Address Formats

Attralus uses at least 1 format(s):

Attralus Email Formats	Example	Percentage
FLast@attralus.com	JDoe@attralus.com	48%
First@attralus.com	John@attralus.com	2%
FLast@attralus.com	JDoe@attralus.com	48%
First@attralus.com	John@attralus.com	2%

Frequently Asked Questions

Where is Attralus 's headquarters located?

Attralus 's main headquarters is located at 50 Francisco St Suite 450 San Francisco, California 94133 US. The company has employees across 1 continents, including North America.

What is Attralus 's official website and social media links?

Attralus 's official website is attralus.com and has social profiles on LinkedIn.

How much revenue does Attralus generate?

As of September 2024, Attralus 's annual revenue reached $3.8M.

What is Attralus 's SIC code NAICS code?

Attralus 's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Attralus have currently?

As of September 2024, Attralus has approximately 31 employees across 1 continents, including North America. Key team members include Chief Executive Officer: S. G.Chief Executive Officer: S. G.Chief Business Officer: G. F.. Explore Attralus 's employee directory with LeadIQ.

What industry does Attralus belong to?

Attralus operates in the Biotechnology Research industry.

What technology does Attralus use?

Attralus 's tech stack includes WordPressCookieYesMySQLGoogle Font APIjQueryHTTP/3Open GraphOpenResty.

What is Attralus 's email format?

Attralus 's email format typically follows the pattern of . Find more Attralus email formats with LeadIQ.

How much funding has Attralus raised to date?

As of September 2024, Attralus has raised $56M in funding. The last funding round occurred on Feb 06, 2024 for $56M.

Attralus

Biotechnology ResearchCalifornia, United States11-50 Employees

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.

Company Overview

Headquarters: 50 Francisco St Suite 450 San Francisco, California 94133 US
Website: attralus.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 11-50

Media & News

Funding & Financials

$56M
Attralus has raised a total of $56M of funding over 3 rounds. Their latest funding round was raised on Feb 06, 2024 in the amount of $56M.
$10M
Attralus 's revenue is in the range of $10M

Funding & Financials

$56M
Attralus has raised a total of $56M of funding over 3 rounds. Their latest funding round was raised on Feb 06, 2024 in the amount of $56M.
$10M
Attralus 's revenue is in the range of $10M

Company Leadership

S. G.
Chief Executive Officer
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. G.
Chief Executive Officer
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. F.
Chief Business Officer
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. B.
Chief Medical Officer
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. T.
Vice President Finance
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

A. V.
Vice President, Head Of Toxicology, Drug Disposition, And Pk/Pd
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. K.
Senior Vice President, Head Of Cmc
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. B.
Head Of It Operations
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. S.
Sr. Director, Head Of Clinical Data Management
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. H.
Head Of Human Resources
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Attralus and Millions of Other Companies
Sign up for full access to Attralus information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Attralus

Analytix

Lumis

Analytik

Attralus Tech Stack

Media & News

Attralus, Inc. received financing of $56M in financing on Feb 6th '24.

Attralus, Inc. hired James Testa as Vice President of Finance on Feb 10th '22.

Attralus, Inc. launched preclinical data for AT-03 on Dec 13th '21.

Attralus, Inc. received financing of $116M in Series B on Sep 8th '21.

Attralus, Inc. hired Alexander Denner as Board of Directors on Sep 8th '21.

Attralus, Inc. hired Jake Bauer as independent director on Jul 28th '21.

Attralus, Inc. is developing pan-amyloid removal treatments for systemic amyloidosis.

Attralus 's Email Address Formats

Frequently Asked Questions

Where is Attralus 's headquarters located?

What is Attralus 's official website and social media links?

How much revenue does Attralus generate?

What is Attralus 's SIC code NAICS code?

How many employees does Attralus have currently?

What industry does Attralus belong to?

What technology does Attralus use?

What is Attralus 's email format?

How much funding has Attralus raised to date?

Attralus

Company Overview

Media & News

Attralus, Inc. received financing of $56M in financing on Feb 6th '24.

Attralus, Inc. hired James Testa as Vice President of Finance on Feb 10th '22.

Attralus, Inc. launched preclinical data for AT-03 on Dec 13th '21.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?